Sandoz CEO: Trump Tariffs on Generics Not Major Threat
Sandoz Group is negotiating with the U.S. government regarding manufacturing investments and does not consider President Trump's proposed tariffs on generic medicines a major threat, according to the company's CEO.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)